How New Treatments And U.S. Policy Changes Are Driving Healthcare Stocks
Source: SeekingAlpha
2025-09-12 11:30:00 ET
Pharma and biotech stocks have struggled lately as uncertainty over the potential impact of tariffs and pricing pressures. Jasper Hellweg, Security Analyst with Argus Research, joins MoneyTalk to discuss how new treatment types and U.S. policy changes could be catalysts for the healthcare sector....
Read the full article on Seeking Alpha
For further details see:
How New Treatments And U.S. Policy Changes Are Driving Healthcare Stocks
Global X Genomics & Biotechnology ETF
NASDAQ: GNOM
GNOM Trading
-1.44% G/L:
$43.0801 Last:
1,766 Volume:
$43.88 Open:
